LIVE
BREAKING
Russia Launches Massive Kyiv Bridges Attack, Killing FiveCOP31 Climate Champions Close the Action Agenda: “Science Calls, the Action Agenda Delivers”Magnitude 5.1 Earthquake Strikes Near Soledad in Central CaliforniaTaiwan Flags Nearly 2,700 China-Linked Accounts to Meta Ahead of ElectionsCOP31’s Final Day: Closing Plenary Under Way as Green Zone Hosts Its Last EventsEthiopia-Eritrea Tensions Escalate as Drone and Artillery Strikes Hit BadmeCOP31 Closes Today, but the Climate Message Still Has Not Reached Most PeopleTrump Official Floated Ceding Guyanese Territory to Venezuela, Sources SayCOP31 Draft Drops Children’s Climate Protections as Young Advocates Demand RestorationCOP31: The Race to Make Green Fuel for Flying — From China’s Refineries to Africa’s First SAF PlantsIndonesia Tells COP31: Planting Trees Is Not Enough — Restoration Must Go ‘Beyond Planting’Haiti Police Kill 34 Suspected Gang Members in Martissant OperationCOP31’s Waste Methane Gap: Campaigners Say Prevention Must Come Before CaptureCOP31 Enters Final Day With Fossil-Fuel Language Still Missing and Key Tracks UnresolvedTbilisi Building Explosion Kills Six, Including Two ChildrenSouth African Reserve Bank Holds Interest Rate at 7.25% in Split VoteSomalia Orders UAE Ambassador to Leave Within 72 HoursKuaishou Unveils Kling 4.0 as Revenue Falls to RMB31.6 Billion in Third QuarterGeneDx Names Everett Cunningham as Chief ExecutiveFrederiksen Rejects Multiculturalism in Podcast Remarks on Danish IdentityRussia Launches Massive Kyiv Bridges Attack, Killing FiveCOP31 Climate Champions Close the Action Agenda: “Science Calls, the Action Agenda Delivers”Magnitude 5.1 Earthquake Strikes Near Soledad in Central CaliforniaTaiwan Flags Nearly 2,700 China-Linked Accounts to Meta Ahead of ElectionsCOP31’s Final Day: Closing Plenary Under Way as Green Zone Hosts Its Last EventsEthiopia-Eritrea Tensions Escalate as Drone and Artillery Strikes Hit BadmeCOP31 Closes Today, but the Climate Message Still Has Not Reached Most PeopleTrump Official Floated Ceding Guyanese Territory to Venezuela, Sources SayCOP31 Draft Drops Children’s Climate Protections as Young Advocates Demand RestorationCOP31: The Race to Make Green Fuel for Flying — From China’s Refineries to Africa’s First SAF PlantsIndonesia Tells COP31: Planting Trees Is Not Enough — Restoration Must Go ‘Beyond Planting’Haiti Police Kill 34 Suspected Gang Members in Martissant OperationCOP31’s Waste Methane Gap: Campaigners Say Prevention Must Come Before CaptureCOP31 Enters Final Day With Fossil-Fuel Language Still Missing and Key Tracks UnresolvedTbilisi Building Explosion Kills Six, Including Two ChildrenSouth African Reserve Bank Holds Interest Rate at 7.25% in Split VoteSomalia Orders UAE Ambassador to Leave Within 72 HoursKuaishou Unveils Kling 4.0 as Revenue Falls to RMB31.6 Billion in Third QuarterGeneDx Names Everett Cunningham as Chief ExecutiveFrederiksen Rejects Multiculturalism in Podcast Remarks on Danish Identity
Technology

First AI-Designed Virus Given to a Patient in Medical Milestone

News Desk 2Published October 31, 2026
First AI-Designed Virus Given to a Patient in Medical Milestone
Share this story

Doctors have treated a patient with viruses designed by artificial intelligence for the first time, marking a milestone in the search for new weapons against infections that no longer respond to antibiotics.

The experimental treatment was developed by San Francisco-based company Radical Numerics, whose AI model, Omnii-1, designed a cocktail of bacteriophages — viruses that attack bacteria but leave human cells untouched. It was given to a patient under a physician-led compassionate-use programme authorised by the United States Food and Drug Administration (FDA), after standard antibiotics and existing phage treatments had failed.

FAKTA

  • What happened: the first clinical use of AI-designed bacteriophages in a human patient.
  • Who: Radical Numerics, a San Francisco-based AI company, using its model Omnii-1.
  • The patient: a person with an antibiotic-resistant E. coli infection, as reported by The New York Times.
  • How it was tested: the phage cocktail was tried against bacteria taken from the patient in the laboratory, where it eliminated the resistant sample, before it was administered.
  • Status: the report has not been peer-reviewed, and the treatment outcome has not been disclosed; a single case cannot prove safety or effectiveness.

How the AI designs its viruses

Traditional phage therapy means hunting through nature for a virus that attacks a patient’s exact bacterial strain. Omnii-1 takes a different route: it is a multimodal genome language model trained on measured interactions between phages and bacteria, and it edits parts of existing phages so they recognise and attach to the bacteria causing the infection.

In company tests against 37 previously unseen E. coli strains, Omnii-1 identified active phages for 91.4 percent of eligible strains using just two phages, outperforming two specialised prediction systems. Radical Numerics says the approach could cut the design process to a few days, allowing doctors to respond far more quickly to serious infections.

Why it matters — and why caution is needed

Antibiotic resistance is one of the greatest threats facing modern medicine. A 2024 study published in The Lancet projected that bacterial antimicrobial resistance could directly cause 39.1 million deaths worldwide between 2025 and 2050. When antibiotics fail, doctors are left with few options, and phage therapy is among the most promising alternatives — but matching the right phage to each patient has so far been slow and difficult.

Caution is essential. The company’s report has not been published in a scientific journal or independently peer-reviewed, and Radical Numerics has not disclosed the patient’s detailed diagnosis, clinical course or whether the infection was cleared, citing patient privacy. Doctors will need months of monitoring to confirm the infection does not return. Earlier AI phage research, including work by Stanford University and the Arc Institute with a model called Evo 2, had only ever destroyed bacteria in laboratory experiments — never before in a human patient.

If further studies confirm the approach, doctors could one day design personalised treatments within days rather than weeks. For now, this first patient is a proof of possibility, not yet a proven cure.

Related Stories

Planet & environment

Climate & Sustainability

News, stories and solutions driving change towards a greener and more sustainable planet for future generations.

COP31 Climate Champions Close the Action Agenda: “Science Calls, the Action Agenda Delivers”
Featured story

COP31 Climate Champions Close the Action Agenda: “Science Calls, the Action Agenda Delivers”

COP31's Climate High-Level Champions closed the Global Climate Action Agenda in Antalya on Thursday, reporting on delivery across electrification, cities and nature — from new grids to school kitchens in Tanzania.

Read full story

GREEN JOURNALISM

Every Action Counts

Small steps today, big impact tomorrow.

Explore more stories